DE68926294T2 - Antigen gegen diabetes - Google Patents

Antigen gegen diabetes

Info

Publication number
DE68926294T2
DE68926294T2 DE68926294T DE68926294T DE68926294T2 DE 68926294 T2 DE68926294 T2 DE 68926294T2 DE 68926294 T DE68926294 T DE 68926294T DE 68926294 T DE68926294 T DE 68926294T DE 68926294 T2 DE68926294 T2 DE 68926294T2
Authority
DE
Germany
Prior art keywords
cell
antiges
species
against diabetes
somatic cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68926294T
Other languages
English (en)
Other versions
DE68926294D1 (de
Inventor
Kim Sze Tan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KS Biomedix Ltd
Original Assignee
KS Biomedix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888803757A external-priority patent/GB8803757D0/en
Priority claimed from GB888803756A external-priority patent/GB8803756D0/en
Application filed by KS Biomedix Ltd filed Critical KS Biomedix Ltd
Application granted granted Critical
Publication of DE68926294D1 publication Critical patent/DE68926294D1/de
Publication of DE68926294T2 publication Critical patent/DE68926294T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6843—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a material from animals or humans
DE68926294T 1988-02-18 1989-02-15 Antigen gegen diabetes Expired - Fee Related DE68926294T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888803757A GB8803757D0 (en) 1988-02-18 1988-02-18 Antigens against autoimmune diseases
GB888803756A GB8803756D0 (en) 1988-02-18 1988-02-18 Hybrid cells for producing biological products
PCT/GB1989/000138 WO1989007601A1 (en) 1988-02-18 1989-02-15 Antigens against autoimmune diseases

Publications (2)

Publication Number Publication Date
DE68926294D1 DE68926294D1 (de) 1996-05-23
DE68926294T2 true DE68926294T2 (de) 1996-09-19

Family

ID=26293506

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68926294T Expired - Fee Related DE68926294T2 (de) 1988-02-18 1989-02-15 Antigen gegen diabetes

Country Status (5)

Country Link
EP (1) EP0401271B1 (de)
JP (1) JPH03502795A (de)
AT (1) ATE136901T1 (de)
DE (1) DE68926294T2 (de)
WO (1) WO1989007601A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776093A (en) * 1985-07-05 1998-07-07 Immunomedics, Inc. Method for imaging and treating organs and tissues
SE9402090D0 (sv) * 1994-06-14 1994-06-14 Rudolf Valenta Recombinent molecules, proteins/polypeptides, host systems and diagnostic and therapeutic methods for atopy
AU5744800A (en) * 1999-06-16 2001-01-02 Biocrystal Limited Vaccine formulations and methods for immunizing an individual against shed antigen-specific b cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL69686A (en) * 1983-09-11 1988-03-31 Yeda Res & Dev Compositions containing cell membrane proteins and process for their preparation
EP0155676A3 (de) * 1984-03-19 1988-02-24 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zur Gewinnung der globulären Domäne von Basalmembrankollagen und immunologische Bestimmung von Basalmembranmaterial und Autoantikörpern
AU7281787A (en) * 1986-04-01 1987-10-20 Genelabs Incorporated Immortalized cells which produce tissue-specific products
ZA874410B (en) * 1986-06-24 1988-04-27 Merrell Dow Pharma Fusion products

Also Published As

Publication number Publication date
ATE136901T1 (de) 1996-05-15
WO1989007601A1 (en) 1989-08-24
EP0401271A1 (de) 1990-12-12
EP0401271B1 (de) 1996-04-17
JPH03502795A (ja) 1991-06-27
DE68926294D1 (de) 1996-05-23

Similar Documents

Publication Publication Date Title
ATE13317T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches prothymozytantigen; antikoerper und verfahren zu seiner herstellung; diagnostische und therapeutische verwendungen und diesen antikoerper enthaltende pharmazeutische zusammensetzungen.
IL59919A0 (en) A monoclonal antibody of class lgg,its preparation and pharmaceutical compositions containing it
DK609985A (da) Adhesin-antigener, antistoffer mod disse og dna-fragmenter, som indkoder antigenerne
DE69426564T2 (de) Herstellung und verwendung von transgenen mäusen mit fehlender expression von cd28
ES8303098A1 (es) Un metodo de preparacion de un anticuerpo monoclonal.
NO159882C (no) Monoklonalt antistoff.
JPS6463376A (en) Hybridmer
ES497423A0 (es) Un anticuerpo monoclonico
DE68926294D1 (de) Antigen gegen diabetes
ATE125870T1 (de) Hiv-spezifische monoklonale antikörper und hybridome zu ihrer herstellung.
ATE109004T1 (de) Toleranzinduktion gegenüber einem fremdantigen.
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
GB8823081D0 (en) Human monoclonal antibodies specifically recognizing rabies virus cells cells producing the same formulations containing the same
ZA892509B (en) Human monoclonal antibodies specifically recognizing rabies virus cells,cells producing the same,formulations containing the same and the production of all thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee